These results, along with a previous report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a unique solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Conditions. Healthy joints make it https://epeliy702bwr0.blogdun.com/profile